anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

200,941-201,000 of 319,975

filter-aware
08
The slide uses a dual-axis chart to show revenue growth alongside emission reduction. It highlights specific targets for 2025 and 2026.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
09
Includes a map of global forest commitments and specific metrics for reforestation and water footprint reduction.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
10
Slide 10 of a presentation; includes footnotes explaining SET/SET-1 and specific targets.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future VisionLoop · Golden Circle1 hit
11
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
12
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
13
The slide compares 2021 and 2022 performance across Governance, R&D, and Product Delivery, alongside a historical trend line from 2012-2022.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
14
Includes a map of Africa highlighting current and planned program countries.AstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
15
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
16
AstraZeneca | ESG Presentation Deck | 16 slidesAstraZeneca | ESG Presentation Deck | 16 slides · AstraZeneca
Conference presentation Investor relations Beat · Future State1 hit
01
Slide 1
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
02
Includes a date note at the bottom left: 'Note: Unless otherwise stated, this presentation is as of March 2nd, 2023'ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
03
Numbered list format used to summarize key company pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
04
Uses a hierarchical structure to break down the objective into three strategic pillars.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Solution1 hit
05
The slide uses a Gantt-style visualization to show the progress of drug development programs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · SolutionLoop · Why Now1 hit
06
The slide uses a timeline framework to show past achievements and future milestones.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · RoadmapLoop · Why Now1 hit
07
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
08
The slide uses a vertical timeline-like structure to highlight the 'Huge Need for Development' and a map/metric section for global impact.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
09
Includes a quote from Keith Nuechterlein and specific Cohen's d effect size metrics.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Problem1 hit
10
The slide uses a vertical process flow to demonstrate the progression of clinical validation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
11
The slide uses a dual-panel layout to compare animal model data (left) with human Phase 1 clinical trial data (right).ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
12
The slide highlights that low doses (40 or 80 mg TID) of RL-007 show superior cognitive performance compared to higher doses and Pregabalin.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
13
The slide uses a standard clinical trial flow diagram to illustrate the study protocol.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
14
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
15
The slide uses a split-layout: left side defines the disease and market size, right side outlines the clinical 'urgent need' for innovation.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
16
The slide uses a line chart to show MADRS score changes over 12 weeks, highlighting the 25mg dose efficacy.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
17
The slide uses a timeline-based process diagram to illustrate clinical trial protocols.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
18
The slide uses a split layout: a dark sidebar for product specs and a white main area for clinical data visualization.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
19
The slide uses a split-layout with a sidebar for product specs and a main area for study design and results.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
20
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
21
The slide uses a combination of a disease overview, market sizing metrics, and a 'massive unaddressed need' framework to justify the problem.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
22
The slide uses a split-layout with a left-hand sidebar for product specs and a right-hand main area for clinical evidence and trial design.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
23
The slide uses a numbered list to highlight key safety findings alongside a detailed data table.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
24
The slide uses topographical brain maps to visualize EEG data changes.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations Beat · Traction1 hit
25
The chart uses error bars and statistical significance markers (asterisks) to compare dose groups against a zero baseline.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
26
The slide uses a checkmark matrix to highlight the competitive advantages of the proposed drug.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
27
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
28
Uses a timeline-style visual to list key statistics about the OUD crisis.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
29
The slide uses a line chart to demonstrate reduction in HCQN subscales over time, and a process diagram to outline the ongoing Phase 1/2 trial stages.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
30
The slide uses a feature-comparison matrix to highlight the unique value proposition of DMX-1002 (Ibogaine) against standard MAT and withdrawal support drugs.ATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
31
ATAI | Investor Presentation Deck | 31 slidesATAI | Investor Presentation Deck | 31 slides · atai Life Sciences
Pitch deck Investor relations 1 hit
01
Slide 1
Azerion | Investor Presentation Deck | 30 slidesAzerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Golden Circle1 hit
02
Uses a funnel-like visual to connect user growth to market size.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · Market SizeLoop · Golden Circle1 hit
03
The slide uses a value-chain style diagram to illustrate the fragmentation of the ad-tech market.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a value chain framework to show disintermediation or integration of ad-tech services.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
05
The slide uses a value-chain style diagram to illustrate the platform ecosystem.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
06
The slide uses a hub-and-spoke style layout to categorize metrics into Customers and Partners, with a background map indicating global reach.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
07
The revenue split chart uses a nested donut/sunburst style to show segments.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · TractionLoop · Cost Of Inaction1 hit
08
The slide uses a value-chain style flow to map demand sources to supply channels and their corresponding revenue streams.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Beat · Business ModelLoop · Cost Of Inaction1 hit
09
The slide uses a hub-and-spoke style layout to show how these five pillars support the central Azerion brand.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
10
The slide uses a grid-based layout to contrast Azerion's vertical integration against fragmented competitors.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
11
The slide uses a 4-column grid layout to define audience preferences.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
12
The slide uses a logo-grid layout to demonstrate reach across different content verticals.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
13
The slide uses a comparative structure to contrast two business models (Casual vs Premium) and provides aggregate scale metrics at the bottom.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
14
The slide uses a 'from X to Y' framing to demonstrate the breadth of the platform's utility.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
15
The slide uses a funnel-like visual structure to map business segments to specific value propositions.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
16
Azerion | Investor Presentation Deck | 30 slidesAzerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations Loop · Cost Of Inaction1 hit
17
Includes a waterfall chart for cash conversion and net debt.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
18
The slide uses a combination of stacked bar charts and dual-axis line charts to demonstrate operational efficiency and financial scaling.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
19
The slide uses a combination of combo charts and bulleted lists to correlate operational KPIs with financial outcomes.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit
20
The slide outlines three pillars of value optimization with a specific financial target at the bottom.Azerion | Investor Presentation Deck | 30 slides · Azerion
Pitch deck Investor relations 1 hit